IBO (Impact BioMedical) Institutional Ownership: 3.45% (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IBO Impact BioMedical Inc IBO
10 GF Score
Price $0.44
! 6 Warning Signs
View Full Analysis

What is Impact BioMedical Institutional Ownership?

Impact BioMedical IBO -1.57% 10 Institutional Ownership is 3.45% as of Aug. 14, 2026. GuruFocus rates IBO with a GF Score™ of 10/100. The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Impact BioMedical's institutional ownership is 3.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Impact BioMedical's Insider Ownership is 0.47%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Impact BioMedical's Float Percentage Of Total Shares Outstanding is 10.89%.

Impact BioMedical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Impact BioMedical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Impact BioMedical Institutional Ownership Chart

Impact BioMedical Historical Data

The historical data trend for Impact BioMedical can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.88 0.88 0.94 0.97 1.00 2.43 2.43 2.43 2.40 2.40
IBO
10GF Score
Impact BioMedical Inc IBO
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Impact BioMedical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.45% mean?
Impact BioMedical (IBO) has a Institutional Ownership of 3.45% as of Aug. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Impact BioMedical and its competitors.
Is Impact BioMedical's Institutional Ownership too high?
Impact BioMedical's current Institutional Ownership is 3.45%. Overall, Impact BioMedical has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Impact BioMedical's Institutional Ownership compare to ATYR and MCRB?
Impact BioMedical's Institutional Ownership of 3.45% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Impact BioMedical and its competitors. Impact BioMedical's current Institutional Ownership is 3.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impact BioMedical stock overvalued right now?
Impact BioMedical (IBO) has a current Institutional Ownership of 3.45%. The current Institutional Ownership is 3.45%. Impact BioMedical's overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Impact BioMedical (IBO), the current Institutional Ownership is 3.45% as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Impact BioMedical Business Description

Address 1400 Broadfield Boulevard, Suite 130, Houston, TX, USA, 77084
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
10GF Score

Get the complete analysis for IBO

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.44
Price